ENTRY       D11717                      Drug
NAME        Tepotinib (USAN/INN)
FORMULA     C29H28N6O2
EXACT_MASS  492.2274
MOL_WEIGHT  492.5716
CLASS       Antineoplastic
             DG01918  Tyrosine kinase inhibitor
              DG01917  Receptor tyrosine kinase inhibitor
            Metabolizing enzyme substrate
             DG02918  CYP2C8 substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      ATC code: L01EX21
            Chemical structure group: DG03087
            Product (DG03087): D11073<JP/US>
EFFICACY    Antineoplastic
TARGET      MET [HSA:4233] [KO:K05099]
  PATHWAY   hsa04014(4233)  Ras signaling pathway
            hsa04151(4233)  PI3K-Akt signaling pathway
            hsa05200(4233)  Pathways in cancer
METABOLISM  Enzyme: CYP3A4 [HSA:1576], CYP2C8 [HSA:1558]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01E PROTEIN KINASE INHIBITORS
                L01EX Other protein kinase inhibitors
                 L01EX21 Tepotinib
                  D11717  Tepotinib (USAN/INN)
            Drug groups [BR:br08330]
             Antineoplastic
              DG01918  Tyrosine kinase inhibitor
               DG01917  Receptor tyrosine kinase inhibitor
                DG03087  Tepotinib
                 D11717  Tepotinib
             Metabolizing enzyme substrate
              DG02918  CYP2C8 substrate
               DG03087  Tepotinib
                D11717  Tepotinib
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG03087  Tepotinib
                 D11717  Tepotinib
            Target-based classification of drugs [BR:br08310]
             Protein kinases
              Receptor tyrosine kinases (RTK)
               MET family
                MET
                 D11717  Tepotinib (USAN/INN)
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D11717
            Drug groups [BR:br08330]
             Antineoplastic
              DG01918  Tyrosine kinase inhibitor
               DG01917  Receptor tyrosine kinase inhibitor
                DG03087  Tepotinib
             Metabolizing enzyme substrate
              DG02918  CYP2C8 substrate
               DG03087  Tepotinib
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG03087  Tepotinib
DBLINKS     CAS: 1100598-32-0
            PubChem: 405226583
            PDB-CCD: 3E8
ATOM        37
            1   C8y C    12.2500  -19.6000
            2   C8x C    12.2500  -18.2000
            3   C8x C    13.4400  -17.5000
            4   C8x C    14.7000  -18.2000
            5   C8y C    14.7000  -19.6000
            6   C8x C    13.4400  -20.3000
            7   C3b C    11.0600  -20.3000
            8   N3a N     9.8000  -21.0000
            9   C8y C    15.8900  -20.3000
            10  N5x N    17.0800  -19.6000
            11  N4y N    18.3400  -20.3000
            12  C8y C    18.3400  -21.7000
            13  C8x C    17.1500  -22.4000
            14  C8x C    15.8900  -21.7000
            15  C1b C    19.5300  -19.6000
            16  C8y C    20.7200  -20.3000
            17  C8x C    21.9100  -19.6000
            18  C8y C    23.1700  -20.3000
            19  C8x C    23.1700  -21.7000
            20  C8x C    21.9800  -22.4000
            21  C8x C    20.7200  -21.7000
            22  C8y C    24.3600  -19.6000
            23  N5x N    24.3600  -18.2000
            24  C8x C    25.6200  -17.5000
            25  C8y C    26.8100  -18.2000
            26  C8x C    26.8100  -19.6000
            27  N5x N    25.6200  -20.3000
            28  O2a O    28.0000  -17.5000
            29  C1b C    29.1900  -18.2000
            30  C1y C    30.3800  -17.5000
            31  C1x C    30.3800  -16.1000
            32  C1x C    31.6400  -15.4000
            33  N1y N    32.8300  -16.1000
            34  C1x C    32.8300  -17.5000
            35  C1x C    31.6400  -18.2000
            36  C1a C    34.0200  -15.4000
            37  O5x O    19.5300  -22.4000
BOND        41
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     1   7 1
            8     7   8 3
            9     5   9 1
            10    9  10 2
            11   10  11 1
            12   11  12 1
            13   12  13 1
            14   13  14 2
            15    9  14 1
            16   11  15 1
            17   15  16 1
            18   16  17 2
            19   17  18 1
            20   18  19 2
            21   19  20 1
            22   20  21 2
            23   16  21 1
            24   18  22 1
            25   22  23 2
            26   23  24 1
            27   24  25 2
            28   25  26 1
            29   26  27 2
            30   22  27 1
            31   25  28 1
            32   28  29 1
            33   29  30 1
            34   30  31 1
            35   31  32 1
            36   32  33 1
            37   33  34 1
            38   34  35 1
            39   30  35 1
            40   33  36 1
            41   12  37 2
///
